hivinfect
patient
may
acquir
new
viral
coinfect
may
also
experi
reactiv
worsen
exist
viral
infect
includ
activ
smolder
latent
infect
hivinfect
patient
may
predispos
viral
infect
due
immunodefici
risk
factor
common
hiv
virus
number
affect
kidney
either
direct
infect
deposit
immun
complex
review
discuss
renal
manifest
treatment
hepat
c
viru
bk
viru
adenoviru
cytomegaloviru
parvoviru
patient
hiv
diseas
also
discuss
approach
identif
new
viral
renal
pathogen
use
viral
gene
chip
identifi
viral
dna
rna
hepat
c
viru
hcv
coinfect
common
among
hivinfect
patient
approxim
one
third
hivinfect
individu
worldwid
also
infect
hcv
higher
rate
coinfect
observ
patient
infect
parenter
given
high
preval
coinfect
hcvrelat
kidney
diseas
import
consider
patient
hivhcv
coinfect
present
renal
manifest
varieti
glomerulonephritid
associ
hcv
infect
includ
membran
glomerulopathi
focal
segment
glomerulosclerosi
fsg
commonli
membranoprolif
glomerulonephr
mpgn
without
cryoglobulinemia
similar
spectrum
glomerular
diseas
observ
patient
concurr
hiv
hcv
infect
addit
postinfecti
glomerulonephr
immunotactoid
glomerulopathi
fibrillari
glomerulonephr
report
popul
two
seri
review
clinic
renal
patholog
featur
patient
coinfect
hiv
hcv
stoke
et
al
report
renal
find
seven
africanamerican
five
hispan
coinfect
intraven
drug
user
present
proteinuria
hematuria
renal
dysfunct
major
hypertens
edema
cryoglobulinemia
renal
biopsi
find
includ
mpgn
patient
mesangi
prolifer
glomerulonephr
patient
membran
glomerulonephr
one
patient
one
case
collaps
fsg
immun
complex
deposit
three
patient
die
five
patient
progress
end
stage
renal
diseas
esrd
mean
month
cheng
et
al
examin
impact
hiv
infect
renal
patient
surviv
patient
hcvassoci
glomerular
diseas
intraven
drug
user
mean
age
year
major
patient
africanamerican
hcv
glomerular
diseas
becam
clinic
evid
set
moder
advanc
hiv
diseas
patient
cell
count
aid
clinic
present
similar
isol
hcvassoci
glomerular
diseas
renal
insuffici
nephrot
rang
proteinuria
major
renal
biopsi
find
includ
case
mpgn
rel
high
frequenc
mpgn
type
three
patient
membran
glomerulonephr
atyp
histolog
featur
includ
diffus
mesangi
prolifer
deposit
focal
segment
endocapillari
prolif
exud
glomerulonephr
one
fsg
collaps
featur
suggest
overlap
hivan
sever
notabl
differ
cohort
coinfect
patient
isol
hcvglomerular
diseas
degre
renal
insuffici
present
hiv
coinfect
patient
advanc
report
hcvassoci
mpgn
histor
control
although
may
reflect
delay
renal
biopsi
coinfect
patient
lower
preval
hypocomplementemia
cryoglobulinemia
compar
report
hcvglomerular
diseas
without
hiv
one
patient
cryoglobulinemia
organ
deposit
differ
high
rate
substructur
identif
glomerular
deposit
hcvglomerular
diseas
hivneg
patient
renal
outcom
wors
coinfect
patient
compar
patient
isol
hcvglomerular
diseas
similar
creatinin
valu
higher
percentag
rapid
progress
esrd
progress
rapidli
advanc
renal
failur
requir
dialysi
median
interv
two
month
biopsi
similarli
poor
cours
coinfect
patient
report
stoke
et
al
addit
mortal
high
median
combin
renalpati
surviv
month
clinic
cours
close
resembl
hivan
rather
hcvglomerular
diseas
although
clinic
cours
isol
hcvassoci
renal
diseas
vari
dramat
patient
progress
rapidli
esrd
author
specul
combin
influenc
complex
glomerular
lesion
higher
baselin
renal
insuffici
greater
viral
burden
black
race
may
promot
rapid
renal
deterior
higher
mortal
hivinfect
patient
hcvassoci
glomerular
diseas
although
coexist
hiv
hcv
infect
common
rel
case
hcvrelat
renal
diseas
hiv
patient
describ
literatur
sever
factor
may
contribut
observ
clinic
present
hcvassoci
glomerular
diseas
often
similar
hivan
featur
serv
clue
presenc
hcv
glomerular
diseas
hypocomplementemia
cryoglobulinemia
may
present
thu
mani
patient
may
undergo
renal
biopsi
distinguish
diseas
also
renal
manifest
typic
becom
clinic
appar
fifth
sixth
decad
life
longstand
hcv
infect
prior
use
highli
activ
antiretrovir
therapi
art
unlik
hivinfect
patient
surviv
long
enough
manifest
renal
diseas
relat
hcv
improv
surviv
associ
art
complic
relat
hcv
infect
includ
glomerular
diseas
like
observ
greater
frequenc
exist
concomit
hiv
infect
patient
hcvglomerular
diseas
make
therapeut
approach
difficult
cours
renal
diseas
appear
aggress
hivinfect
patient
may
greater
resist
interferon
alpha
coinfect
patient
although
interferon
shown
antihiv
activ
therapi
hcv
pegyl
interferon
alpha
combin
ribavirin
associ
advers
effect
may
pronounc
hivinfect
patient
anemia
problemat
due
ribavirinrel
hemolysi
interferonrel
suppress
hematopoiesi
zidovudin
may
caus
sever
anemia
use
concurr
antihcv
therapi
addit
concern
drugdrug
interact
ribavirin
nucleosid
revers
transcriptas
inhibitor
didanosin
caus
mitochondri
toxic
pancreat
lactic
acidosi
bk
viru
bkv
nonenvelop
icosahedr
encapsul
dna
viru
belong
papovavirida
famili
jc
viru
member
famili
bkv
infect
widespread
typic
acquir
childhood
approxim
popul
seroposit
bkv
adulthood
major
primari
infect
bkv
immunocompet
host
asymptomat
follow
primari
infect
bkv
frequent
establish
latent
infect
renal
tubular
cell
urinari
tract
epithelia
major
clinic
manifest
appear
result
viral
reactiv
within
genitourinari
tract
condit
cellular
immunosuppress
hemorrhag
cystiti
welldescrib
complic
relat
bkv
reactiv
common
bone
marrow
transplant
also
seen
renal
transplant
recipi
ureter
urethr
stenosi
lead
hydronephrosi
also
report
renal
transplant
popul
bkv
frequent
implic
develop
bkv
nephropathi
associ
high
rate
prematur
allograft
loss
bkv
relat
ill
less
well
character
patient
hiv
infect
two
report
case
sever
hemorrhag
cystiti
due
bkv
patient
hiv
case
symptom
viruria
persist
despit
numer
treatment
includ
ganciclovir
foscarnet
nalidix
acid
cidofovir
publish
case
bkvassoci
nephropathi
patient
aid
case
occur
male
cell
count
present
progress
azotemia
low
grade
proteinuria
bland
urin
sediment
diagnosi
bkv
nephriti
suspect
case
rather
kidney
dysfunct
initi
attribut
altern
diagnos
drug
induc
interstiti
nephriti
kidney
biopsi
reveal
characterist
find
tubulointerstiti
nephriti
mix
inflammatori
infiltr
lymphocyt
monocyt
tubular
epitheli
cell
viral
intranuclear
inclus
presenc
bkv
confirm
immunohistochemisti
situ
hybrid
three
patient
progress
esrd
die
remaind
progress
declin
creatinin
clearanc
unclear
pauciti
report
literatur
regard
bkv
relat
ill
reflect
true
rariti
diseas
among
hivinfect
patient
underrecognit
viral
infect
support
latter
idea
come
numer
case
bkv
relat
tubulointerstiti
nephriti
renal
biopsi
autopsi
specimen
aid
patient
diagnosi
consid
also
observ
support
interact
hiv
bkv
suggest
bkv
may
emerg
aidsassoci
pathogen
hivinfect
patient
higher
incid
bkv
viruria
also
shed
bkv
much
higher
level
immunocompet
control
urinari
bkv
shed
seen
hivinfect
patient
bkv
viruria
well
concentr
bkv
urin
invers
relat
cell
count
may
indic
clinic
diseas
common
among
patient
endstag
aid
although
consist
find
interestingli
recent
studi
indic
viral
protein
tat
may
enhanc
bkv
transcript
suggest
high
hiv
viral
load
may
act
synergist
immunosuppress
state
enhanc
bkv
viral
reactiv
dynam
bkv
reactiv
factor
associ
express
clinic
signific
diseas
well
understood
sever
risk
factor
propos
bkvassoci
hemorrhag
cystiti
aris
set
hematopoiet
stem
cell
transplant
investig
suggest
immun
reconstitut
pattern
diseas
wherebi
diseas
manifest
sever
immun
system
reconstitut
viral
antigen
bladder
wall
recogn
emerg
function
lymphocyt
interestingli
immun
reconstitut
diseas
describ
jc
viru
progress
multifoc
leukoencephalopathi
pml
aid
patient
receiv
art
perhap
immun
reconstitut
syndrom
might
play
similar
role
express
bkv
ill
hivinfect
patient
also
suggest
mutant
bkv
strain
alter
regulatori
region
may
link
progress
infect
develop
renal
diseas
hivinfect
patient
data
need
limit
diagnost
modal
bkv
infect
cytolog
examin
urin
detect
decoy
cell
polyomavirusinfect
cell
enlarg
nucleu
contain
basophil
intranuclear
inclus
good
screen
test
presenc
bkv
urothelium
similar
cytopatholog
seen
virus
includ
jc
viru
adenoviru
quantit
urin
pcr
detect
viral
dna
sensit
urin
cytolog
differenti
bkv
jc
viru
urin
howev
detect
bkv
dna
pcr
high
diseas
specif
high
rate
bkv
shed
among
hivinfect
patient
demonstr
bkv
viremia
plasma
pcr
help
link
bkv
replic
presenc
diseas
nevertheless
relationship
bkv
viruria
viremia
cutoff
predict
valu
bkv
viruria
viremia
occurr
bkv
relat
diseas
defin
patient
hiv
infect
definit
diagnosi
bkv
relat
renal
diseas
establish
renal
biopsi
show
tubulointerstiti
nephriti
characterist
cytopath
chang
epithelium
renal
tubul
urotheli
line
figur
infect
cell
enlarg
nucleu
gelatin
basophil
inclus
result
accumul
newli
form
virion
electron
microscopi
demonstr
intranuclear
viral
particl
nm
diamet
confirm
polyomaviru
infect
usual
perform
immunohistochem
stain
situ
hybrid
situ
polymeras
chain
reaction
treatment
bkv
relat
ill
remain
major
challeng
current
antivir
drug
proven
efficaci
bk
viru
cidofovir
leflunimid
intraven
immunoglobulin
use
treat
bkv
nephropathi
renal
transplant
patient
success
random
control
trial
perform
cidofovir
vidarabin
gamma
globulin
use
treat
hemorrhag
cystiti
stem
cell
transplant
patient
also
evid
fluoroquinolon
potenti
benefit
prophylact
agent
bkv
infect
stem
cell
transplant
patient
littl
experi
treat
bkv
relat
ill
hivinfect
popul
thu
therapeut
option
extrapol
aforment
patient
popul
reduct
immunosuppress
major
focu
manag
renal
transplant
recipi
bkv
nephropathi
often
lead
stabil
renal
function
reduct
viremia
initi
art
would
analog
approach
hivinfect
patient
therapeut
relev
bkv
infect
unknown
art
shown
benefici
among
hiv
patient
jc
virusassoci
pml
current
data
suggest
routin
screen
bkv
viremia
viruria
benefit
hivinfect
patient
howev
hivinfect
individu
esrd
proceed
renal
transplant
bkv
infect
like
becom
particularli
relev
due
combin
effect
immunosuppress
relat
diseas
antireject
medic
aggress
monitor
protocol
may
warrant
popul
adenoviru
nonenvelop
doublestrand
dna
viru
transmit
human
aerosol
droplet
fecalor
spread
infect
occur
childhood
caus
selflimit
respiratori
gastrointestin
ill
immunocompet
host
contrast
adenovir
infect
lethal
immunocompromis
patient
may
develop
diseas
result
newli
acquir
endogen
reactiv
infect
adenoviru
capabl
caus
dissemin
diseas
organ
specif
syndrom
includ
enter
pneumon
hepat
enceph
urinari
tract
involv
may
manifest
hemorrhag
cystiti
well
describ
complic
bone
marrow
transplant
recipi
sever
acut
necrot
tubulointerstiti
nephriti
also
associ
adenoviru
infect
immunocompromis
individu
associ
high
mortal
may
present
azotemia
gross
hematuria
may
incorrectli
attribut
cystiti
occasion
hydronephrosi
clinic
relev
adenoviru
hivinfect
popul
well
defin
adenovirus
recov
hivinfect
patient
sinc
begin
aid
epidem
surveil
studi
symptomat
asymptomat
adenoviru
excret
gastrointestin
tract
urinari
tract
differ
seri
observ
propos
adenoviru
infect
may
reduc
surviv
hivposit
patient
low
cell
count
although
death
relat
adenoviru
difficult
ascertain
given
presenc
opportunist
infect
isol
report
adenovirusrel
urolog
renal
diseas
popul
mazoy
et
al
recent
describ
year
old
white
male
aid
count
present
gross
hematuria
mild
azotemia
nonnephrot
proteinuria
urin
cultur
urin
pcr
posit
adenoviru
cystiti
suspect
cystoscopi
unremark
renal
biopsi
consist
sever
acut
tubulointerstiti
nephriti
associ
tubular
epitheli
cell
necrosi
intranuclear
viral
inclus
bodi
immunohistochem
stain
antiadenoviru
antibodi
show
strong
intranuclear
cytoplasm
stain
infect
tubular
epitheli
cell
patient
treat
ribavirin
decreas
urin
adenoviru
load
patient
die
shortli
due
superimpos
fungal
infect
two
case
adenoviru
relat
interstiti
nephriti
patient
aid
report
diagnos
post
mortem
also
singl
case
report
sever
hemorrhag
cystiti
attribut
adenoviru
patient
aid
diagnosi
urinari
tract
involv
adenoviru
typic
made
viral
isol
urin
howev
acut
infect
adenoviru
may
shed
stool
urin
mani
month
immunocompromis
host
thu
posit
cultur
result
need
interpret
light
clinic
manifest
quantit
pcr
sensit
tool
detect
adenoviru
genom
blood
institut
routin
perform
urin
unless
request
monitor
respons
antivir
therapi
definit
diagnosi
adenoviru
nephriti
requir
renal
biopsi
major
find
tubulointerstiti
mononuclear
infiltr
smudg
cell
format
nuclear
enlarg
intranuclear
inclus
cell
degener
often
sever
necrot
tubular
necrosi
figur
electron
microscopi
show
crystallin
array
viral
particl
adenoviru
specif
immunohistochem
assay
situ
hybrid
help
confirm
diagnosi
standard
treatment
adenovirusassoci
diseas
hiv
patient
although
control
studi
lack
cidofovir
associ
clinic
improv
bone
marrow
renal
transplant
recipi
anecdot
report
limit
efficaci
antivir
agent
includ
ribavarin
vidarabin
ganciclovir
cytomegaloviru
cmv
doubl
strand
dna
viru
member
herp
viru
famili
cmv
diseas
lifethreaten
opportunist
infect
hivinfect
patient
sever
immunocompromis
patient
aid
progress
loss
immun
function
permit
cmv
reactiv
replic
prior
avail
art
hivinfect
patient
evid
dissemin
cmv
infect
autopsi
although
incid
cmv
diseas
hivinfect
patient
declin
significantli
introduct
art
mani
patient
particularli
cell
count
critic
threshold
still
high
risk
cmv
diseas
immunocompromis
host
cmv
infect
multipl
organ
system
may
caus
broad
array
clinic
present
includ
retin
enceph
pneumon
hepat
gastrointestin
tract
ulcer
hemorrhag
cystiti
tubulointerstiti
nephriti
renal
allograft
hivinfect
patient
cmv
cystiti
report
two
case
dissemin
cmv
infect
implic
caus
nephriti
adult
infant
hiv
infect
renal
histolog
featur
well
describ
either
report
mueller
et
al
describ
child
aid
present
suprapub
pain
gross
hematuria
acut
kidney
injuri
intermitt
urinari
tract
obstruct
symptom
retrograd
ureterographi
consist
ureter
post
mortem
examin
reveal
focal
hemorrhag
lesion
along
entir
length
uret
find
intranuclear
inclus
within
submucos
cell
posit
immunoperoxidas
stain
consist
cmv
infect
final
link
cmv
infect
develop
thrombot
microangiopathi
hypothes
base
case
control
studi
maslo
et
al
endotheli
cmv
inclus
observ
nine
renal
biopsi
hiv
patient
thrombot
microangiopathi
wherea
cmv
detect
control
specimen
parvoviru
small
singl
strand
dna
viru
common
pathogen
infect
individu
adulthood
infect
often
asymptomat
symptomat
typic
caus
erythema
infectiosum
children
arthropathi
adult
individu
hemolysi
ineffect
erythropoiesi
acut
infect
may
lead
transient
aplast
crisi
among
immunocompromis
individu
includ
receiv
immunosuppress
therapi
infect
hiv
infect
becom
persist
due
inabl
mount
effect
humor
andor
cellular
respons
pure
red
cell
aplasia
common
present
persist
parvovir
infect
hivinfect
patient
whether
parvoviru
infect
pathogen
role
renal
urolog
diseas
hivinfect
patient
unknown
christensen
et
al
implic
parvovir
infect
caus
cystiti
patient
hiv
infect
symptom
hematuria
pyuria
began
eight
week
initi
diagnosi
acut
parvoviru
infect
persist
two
year
dna
detect
urin
sampl
much
time
bladder
wall
biopsi
also
weakli
posit
dna
nevertheless
strong
causal
relationship
could
establish
parvovir
infect
symptom
associ
varieti
glomerular
diseas
includ
postinfecti
glomerulonephr
fsg
collaps
fsg
henoch
purpura
thrombot
microangiopathi
immunocompet
immunocompromis
host
difficult
prove
definit
causal
relationship
mani
case
interestingli
moudgil
et
al
detect
dna
renal
biopsi
patient
hivan
although
differ
significantli
compar
control
situ
hybrid
reveal
local
glomerular
pariet
viscer
epitheli
cell
hivan
hiv
identifi
similar
locat
implic
known
perhap
interact
exist
two
virus
may
trigger
express
hivan
renal
manifest
immun
complex
glomerulonephr
pure
specul
point
embark
program
identifi
viral
caus
unexplain
renal
diseas
particular
focus
idiopath
collaps
glomerulopathi
thrombot
microangiopathi
follow
renal
transplant
strong
evid
hivassoci
kidney
diseas
consequ
infect
review
elsewher
issu
prudent
consid
possibl
role
virus
etiolog
renal
manifest
molecular
toolkit
avail
investig
wish
hunt
new
virus
expand
consider
recent
year
yuan
chang
patrick
moor
use
represent
differ
analysi
rda
identifi
sequenc
kaposi
sarcomaassoci
herpesviru
biopsi
aid
patient
kaposi
sarcoma
investig
recent
use
deep
sequenc
identifi
novel
polyomaviru
merkel
cell
carcinoma
approach
technic
difficult
labor
intens
limit
sensit
applic
sampl
type
investig
notabl
ganem
joseph
derisi
design
microarray
abl
detect
sequenc
known
virus
approach
proven
success
detect
known
novel
virus
varieti
sampl
type
diseas
set
use
similar
approach
substanti
adapt
address
question
whether
known
unknown
virus
contribut
pathogenesi
renal
diseas
figur
use
custom
array
agil
technolog
santa
clara
ca
includ
oligonucleotid
virus
genera
averag
viru
repres
individu
featur
distribut
across
conserv
uniqu
region
viral
genom
grid
print
slide
enabl
rel
high
throughput
screen
plasma
peripher
blood
mononuclear
cell
urin
patient
updat
version
array
expand
coverag
viru
famili
polyomavirus
inclus
recent
discov
virus
current
design
review
serv
increas
awar
renal
urolog
manifest
associ
viral
coinfect
hivinfect
patient
tabl
summar
clinic
spectrum
syndrom
well
approach
diagnosi
popul
true
clinic
burden
five
virus
contribut
renal
diseas
impact
morbid
mortal
hivinfect
patient
well
defin
given
preval
virus
gener
popul
increas
suscept
viral
infect
increas
likelihood
reactiv
latent
virus
hivinfect
patient
complic
relat
virus
may
common
current
appreci
challeng
diagnos
viral
infect
may
contribut
underrecognit
major
issu
may
lack
diagnost
suspicion
mani
renal
diseas
affect
patient
similar
overlap
present
also
interpret
diagnost
test
may
straightforward
sinc
difficult
differenti
viral
isol
respons
diseas
may
repres
silent
reactiv
persist
infect
mani
virus
known
level
viremia
viruria
consid
normal
abnorm
patholog
hivinfect
patient
also
underutil
renal
biopsi
patient
popul
would
help
differenti
renal
diseas
associ
virus
etiolog
largescal
studi
systemat
monitor
virus
blood
urin
kidney
specimen
hivinfect
patient
along
cell
count
hiv
viral
load
would
benefici
understand
relationship
marker
immun
function
coinfect
diseas
manifest
risk
factor
outcom
polyoma
infect
renal
allograft
biopsi
show
tubulointerstiti
damag
tubular
epitheli
cell
exhibit
fine
granular
markedli
enlarg
nuclei
ground
glass
appear
arrowhead
typic
seen
polyoma
viru
nephropathi
mononuclear
cell
infiltr
present
period
acidschiff
stain
magnif
immunohistochem
stain
antigen
demonstr
numer
nuclei
tubular
epitheli
cell
tubular
profil
reaction
product
immunoperoxidas
magnif
reprint
permiss
cytomegaloviru
infect
kidney
tissu
show
characterist
larg
cell
basophil
intranuclear
inclus
appear
owl
eye
also
promin
red
cytoplasm
inclus
hematoxylineosin
stain
magnif
adenoviru
infect
kidney
tissu
immunosuppress
patient
show
necrosi
tubular
epitheli
cell
infect
tubular
cell
enlarg
basophil
nuclei
smudg
appear
characterist
adenoviru
hematoxylineosin
stain
start
materi
typic
rna
obtain
cell
tumor
tissu
blood
urin
bodi
fluid
first
dna
strand
synthesi
revers
transcriptas
first
second
dna
strand
amplifi
use
random
pcr
protocol
standard
primer
b
describ
cdna
use
subsequ
cycl
pcr
use
specif
primer
design
amplifi
templat
primer
use
addit
cycl
pcr
incorpor
random
prime
oligom
presenc
aminoallyldutp
thu
allow
label
fluoresc
molecul
purifi
dna
preanneal
human
dna
agil
block
hybrid
buffer
hybrid
onto
agil
microarray
bear
sequenc
viral
open
read
frame
standard
custom
microarray
agil
protocol
employ
wash
microarray
scan
